Efficacy of Hepatic Regional Chemoembolization Via Implanted Drug Delivery System in Prevention of Metastasis and Recurrence after Radical Resection of Primary Liver Cancer

吴志全,樊嘉,邱双健,周俭,贺轶峰,汤钊猷
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2003.11.001
2003-01-01
Abstract:Objective To analyze the efficacy of hepatic regional chemoembolization (HRCE) via implanted drug delivery system (DDS) in the prevention of metastasis and recurrence after radical resection of primary liver cancer (PLC). Methods From January 1995 to December 1997, 308 patients with PLC were surgically treated in our institute. Amongst these patients, 115 received postoperative HRCE via DDS (group A) and the other 193 did not undergo it (group B). Results The follow-up study in all the patients showed that the 1- 3-, 5- and 7-year rates of metastasis and recurrence were significantly lower in group A than in group B (5. 8%, 22. 3%,28. 6% and 43. 9% vs 16. 8%, 39. 7%, 59. 64% and 59. 64%, P0. 001). Meanwhile, the 1-, 3-, 5- and 7-year survival rates wee markedly higher in group A than in group B (96.8%, 91.3%, 84.8% and 77.7% vs 87.3%, 73. 8%, 63. 6% and 58. 7%, P0. 001). The mean time of metastasis and recurrence was longer in group A than in group B (30. 6 months vs 20. 9 months). Conclusions HRCE via DDS after radical resection of PLC is an effective means for prevention of postoperative metastasis and recurrence.
What problem does this paper attempt to address?